Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Toshitaka Sugawara to Aged, 80 and over

This is a "connection" page, showing publications Toshitaka Sugawara has written about Aged, 80 and over.

 
Connection Strength
 
 
 
0.203
 
  1. Sugawara T, Rodriguez Franco S, Sherman S, Kirsch MJ, Colborn K, Franklin O, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer Database. Pancreatology. 2024 Dec; 24(8):1340-1347.
    View in: PubMed
    Score: 0.089
  2. Franklin O, Stoop TF, Rodriguez Franco S, Sugawara T, Ishida H, Halimi A, Colborn K, Gleisner A, Schulick RD, Del Chiaro M. Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer. Pancreatology. 2026 Feb; 26(1):154-163.
    View in: PubMed
    Score: 0.024
  3. Yabushita Y, Park JS, Yoon YS, Ohtsuka M, Kwon W, Choi GH, Imamura M, Matsumoto I, Mizuno S, Matsuyama R, Sakata J, Hayashi H, Takeda Y, Katagiri S, Sugawara T, Kobayashi S, Kawasaki Y, Nagano H, Murase K, Kim HS, Nah YW, Jang JY, Yamaue H, Yoon DS, Yamamoto M, Choi D, Nakamura M, Kim KH, Endo I. Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea. J Hepatobiliary Pancreat Sci. 2024 Jul; 31(7):481-491.
    View in: PubMed
    Score: 0.021
  4. Kobayashi Y, Kiya Y, Sugawara T, Nishioka Y, Hashimoto M, Shindoh J. Expanded Makuuchi's criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection. HPB (Oxford). 2019 08; 21(8):990-997.
    View in: PubMed
    Score: 0.015
  5. Shindoh J, Kawamura Y, Kobayashi Y, Kiya Y, Sugawara T, Akuta N, Kobayashi M, Suzuki Y, Ikeda K, Hashimoto M. Platelet-Albumin Score as a Sensitive Measure for Surgical Risk Prediction and Survival Outcomes of Patients with Hepatocellular Carcinoma. J Gastrointest Surg. 2019 01; 23(1):76-83.
    View in: PubMed
    Score: 0.014
  6. Nishioka Y, Yoshioka R, Gonoi W, Sugawara T, Yoshida S, Hashimoto M, Shindoh J. Fluorine-18-fluorodeoxyglucose positron emission tomography as an objective substitute for CT morphologic response criteria in patients undergoing chemotherapy for colorectal liver metastases. Abdom Radiol (NY). 2018 05; 43(5):1152-1158.
    View in: PubMed
    Score: 0.014
  7. Sasaki K, Shindoh J, Nishioka Y, Sugawara T, Margonis GA, Andreatos N, Pawlik TM, Hashimoto M. Postoperative low hepatitis C virus load predicts long-term outcomes after hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2018 Apr; 117(5):902-911.
    View in: PubMed
    Score: 0.014
  8. Shindoh J, Nishioka Y, Yoshioka R, Sugawara T, Sakamoto Y, Hasegawa K, Hashimoto M, Kokudo N. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion. Ann Surg Oncol. 2016 06; 23(6):1890-6.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)